Sorbe Biotechnology (India) Private Limited - Company Profile

It is a chemicals and materials private limited company based in Mumbai, Maharashtra, India, established in 2001.
2001 Mumbai, Maharashtra, India Active
Last Updated:
About Sorbe Biotechnology (India) Private Limited

Sorbe Biotechnology (India) Private Limited, a active private limited company, was established on 16 March 2001 in Mumbai, Maharashtra, India. Engaging in colorants within the manufacturing sector, it holds CIN: U24239MH2001PTC131256. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹8.75 Cr and a paid-up capital of ₹8.73 Cr.

It upholds a compliant status. Its leadership includes Shashikala Rameshkumar Kabra (Director), Puneet Kabra (Additional Director), Karan Rameshkumar Kabra (Additional Director). Past directors included Deepti Priyadarshini Puneet Kabra, Madhavi Vinay Joshi, Shashikala Rameshkumar Kabra. It holds ₹9.40 Cr open charges and ₹23.56 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 210-213, Dhanlaxmi Service Industrial Estate, Above Navneet Motors, Gokul Nagar, Thane, (West),, Mumbai, Maharashtra, 400601.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2001PTC131256

  • Registration Number

    131256

  • Incorporation Date

    16 March 2001

  • Authorized Capital

    ₹8.75 Cr

  • Paid-Up Capital

    ₹8.73 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 8.75 Cr
  • Paid Up Capital ₹ 8.73 Cr
  • Company Age 24 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 9.40 Cr
  • Satisfied Charges ₹ 23.56 Cr
  • Revenue Growth **** -2.42%
  • Profit Growth **** 299.17%
  • Ebitda **** 95.43%
  • Net Worth 12.21%
  • Total Assets -22.33%
Company report

Sorbe Biotechnology (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sorbe Biotechnology (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sorbe Biotechnology (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Shashikala Rameshkumar Kabra Director 17 Aug 2023 Current
Puneet Kabra Additional Director 01 Jun 2025 Current
Karan Rameshkumar Kabra Additional Director 21 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Additional Director 20 Aug 2010 Past
Pramod Abcsdd Additional Director 20 Aug 2010 Past
Pramod Abcsdd Director 01 Jun 2013 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 08 Aug 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sorbe Biotechnology (India).

Sorbe Biotechnology (India) Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 2.42% decrease. The company also saw a substantial improvement in profitability, with a 299.17% increase in profit. The company's net worth Soared by an impressive increase of 12.21%.

Sorbe Biotechnology (India) revenue growth over time
Sorbe Biotechnology (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-2.42%
*******
*******
*******
*******
Revenue from Operations
*******
-0.93%
*******
*******
*******
*******
Total Assets
*******
-22.33%
*******
*******
*******
*******
Profit or Loss
*******
299.17%
*******
*******
*******
*******
Net Worth
*******
12.21%
*******
*******
*******
*******
EBITDA
*******
95.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sorbe Biotechnology (India)?

In 2024, Sorbe Biotechnology (India) had a promoter holding of 99.97% and a public holding of 0.03%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹94,000,000.00

Satisfied Charges

₹235,607,600.00

Charges Breakdown by Lending Institutions
  • Others : 9.40 Cr
Latest Charge Details
Date Lender Amount Status
30 Jun 2025 Others ₹9.40 Cr Open
10 Oct 2023 Hdfc Bank Limited ₹5.00 Cr Satisfied
16 Jan 2023 Others ₹1.87 Cr Satisfied
31 Jul 2021 Others ₹1.50 Cr Satisfied
23 Feb 2021 Others ₹8.70 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sorbe Biotechnology (India)?

Unlock and access historical data on people associated with Sorbe Biotechnology (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sorbe Biotechnology (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sorbe Biotechnology (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sorbe Biotechnology (India)
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others of Rs. 9.40 Cr registered on 30 Jun 2025 with Charge ID 101141774 was modified on 16 Sep 2025. was documented.

  • Charges

    The activity A charge registered on 10 Oct 2023 via Charge ID 100811867 with Hdfc Bank Limited was fully satisfied on 18 Aug 2025. was completed.

  • Director Appointment

    Progress on Karan Rameshkumar Kabra was appointed as a Additional Director was appointed as a Additional Director on 21 Jul 2025 & has been associated with this company since 6 months 29 days . was documented.

  • Charges

    A charge with Others amounted to Rs. 9.40 Cr with Charge ID 101141774 was registered on 30 Jun 2025. was recorded as a recent event.

  • Director Appointment

    Puneet Kabra was appointed as a Additional Director was appointed as a Additional Director on 01 Jun 2025 & has been associated with this company since 8 months 17 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Sorbe Biotechnology (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sorbe Biotechnology (India) Private Limited?

The CIN of Sorbe Biotechnology (India) Private Limited is U24239MH2001PTC131256.

Where is Sorbe Biotechnology (India) Private Limited headquartered?

Sorbe Biotechnology (India) Private Limited is headquartered at 210-213, Dhanlaxmi Service Industrial Estate, Above Navneet Motors, Gokul Nagar, Thane, (West),, Mumbai, Maharashtra, 400601.

When was Sorbe Biotechnology (India) Private Limited incorporated?

Sorbe Biotechnology (India) Private Limited was incorporated on 16 March 2001.

Who are the current directors of Sorbe Biotechnology (India) Private Limited?

The current directors of Sorbe Biotechnology (India) Private Limited are

What is the primary industry of Sorbe Biotechnology (India) Private Limited?

The primary industry of Sorbe Biotechnology (India) Private Limited is Manufacturing.

Is Sorbe Biotechnology (India) Private Limited a listed company?

Sorbe Biotechnology (India) Private Limited is unlisted.

What is the capital structure of Sorbe Biotechnology (India) Private Limited?

The authorized capital of Sorbe Biotechnology (India) Private Limited is ₹8.75 Cr, and the paid-up capital is ₹8.73 Cr.

What is the compliance status of Sorbe Biotechnology (India) Private Limited?

The compliance status of Sorbe Biotechnology (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available